BPR3P0128 - CAS 1345406-09-8

BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase (RdRp) inhibitor, is effective orally and can inhibit various SARS-CoV-2 variants. It exhibits EC 50 values of 0.62 μM for SARS-CoV-2 and 0.14 μM for HCoV-229E, demonstrating potent anti-pancoronavirus activity at submicromolar concentrations. Additionally, BPR3P0128 displays synergistic antiviral effects when used in combination with Remdesivir [1].

SARS-CoV

Microbiology/Virology

1345406-09-8

C22H18BrN3O2

436.3

CC1=C(C2=NC3=C(C(C(O)=O)=C2)C=C(Br)C=C3)C=NN1C4=C(C)C=CC(C)=C4

-20°C

Ice Packs

Small Compound